FDA
-
-
-
-
-
-
-
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
-
-
-
-
-
-
-
Processa Pharmaceuticals Provides Portfolio and Business Update
-
-
-
-
-
-
-
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
-
-
-
-
-
-
-
Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
-
-
-
-
-
-
-
Processa Pharmaceuticals Inc. (PCSA) Reports Positive Preclinical Data for NGC-Iri
-
-
-
-
-
-
-
Processa Pharmaceuticals Inc. (PCSA) Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
-
-
-
-
-
-
-
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

